nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-75379F7C·Framework v5.13·Pipeline v0.4·Evaluated 16 Nov 2026·OECD: 3.1 Basic medicine·Subfield: Clinical Neurology·Basis: Full text·Type: Laboratory experiment

C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity.

Selvaraj et al.Selvaraj, Livesey, Zhao et al.·2018·Nature communications·10.1038/s41467-017-02729-0 ↗

Primary claim

increased expression of GluA1 AMPA receptor (AMPAR) subunit occurs in MNs with C9ORF72 mutations that leads to increased Ca2+-permeable AMPAR expression and results in enhanced selective MN vulnerability to excitotoxicity.

Tentative · GluA1-specific causation is not isolated by receptor-blocking pharmacology or the edited-line comparisons
In brief

Three isogenic patient-line comparisons link C9ORF72 expansion to altered AMPA receptors and excitotoxic vulnerability, but do not isolate GluA1-specific causation.

ReliabilityCaveats4 of 4 checks completeRead the 3 entries ↓
Fragile — the claim's weakest requirement is that it works through the path described. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

Mutations in C9ORF72 are the most common cause of familial amyotrophic lateral sclerosis (ALS). Here, through a combination of RNA-Seq and electrophysiological studies on induced pluripotent stem cell (iPSC)-derived motor neurons (MNs), we show that increased expression of GluA1 AMPA receptor (AMPAR) subunit occurs in MNs with C9ORF72 mutations that leads to increased Ca2+-permeable AMPAR expression and results in enhanced selective MN vulnerability to excitotoxicity. These deficits are not found in iPSC-derived cortical neurons and are abolished by CRISPR/Cas9-mediated correction of the C9ORF72 repeat expansion in MNs. We also demonstrate that MN-specific dysregulation of AMPAR expression is also present in C9ORF72 patient post-mortem material. We therefore present multiple lines of evidence for the specific upregulation of GluA1 subunits in human mutant C9ORF72 MNs that could lead to a potential pathogenic excitotoxic mechanism in ALS.

Key Claims

Primary finding · Tentative

increased expression of GluA1 AMPA receptor (AMPAR) subunit occurs in MNs with C9ORF72 mutations that leads to increased Ca2+-permeable AMPAR expression and results in enhanced selective MN vulnerability to excitotoxicity.

Fragile — the claim's weakest requirement is that it works through the path described. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

GluA1-specific causation is not isolated by receptor-blocking pharmacology or the edited-line comparisons

Abstract
Quote verified
Secondary · Tentative

mutant C9ORF72 cortical neurons possess predominantly Ca2+-impermeable AMPARs, indicating that mutant C9ORF72-dependent increases in Ca2+-permeable AMPARs are selective to MNs.

the cortical comparison uses one patient line and does not test cortical excitotoxic vulnerability

Discussion
Quote verified
Secondary · Supported

[Excitotoxicity vulnerability] is abolished by CRISPR/Cas9-mediated correction of the C9ORF72 repeat expansion in MNs.

rescue across three patient-line pairs is constrained by one selected clone per line and concurrent wild-type allele editing

Introduction
Quote verified
Secondary · Supported

AMPAR expression is also selectively dysregulated in spinal cord, but not cortical, post-mortem tissue from patients harboring C9ORF72 repeat expansions.

patient-level tissue measurements support the regional association in only three patients and three controls

Introduction, paragraph 3
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#methodological rigour

Repeat correction tested across three patient lines

Three patient-derived lines each have an edited counterpart, linking repeat excision to reversal of the expression and receptor-function phenotypes.

↳ Figures 1, 5–6

#contribution

Convergent assays extend the excitotoxicity mechanism

RNA measurements, protein measurements, receptor physiology, and antagonist-sensitive cell death connect the C9ORF72 phenotype to persistent Ca2+-permeable AMPAR function.

↳ Figures 4–6

#positioning

Alternative mechanisms receive substantive interpretive attention

The Discussion addresses intact GluA2 editing, differences between neuron-only and mixed cultures, and possible contributions from PICK1-dependent receptor trafficking.

↳ Figure 5d; Discussion

Limitations

#methodological rigour

GluA1 causation and selective vulnerability remain unisolated

JTX tests Ca2+-permeable AMPAR involvement rather than GluA1 specifically. The abstract also claims selective vulnerability without a cortical excitotoxicity comparison, extending beyond the receptor measurements in one cortical patient line.

↳ Abstract; Figure 6; Results, cortical-neuron comparison; Discussion

#methodological rigour

Inferential units remain unclear across key assays

Figure 6 distinguishes recorded cells from differentiations but does not state which enters the ANOVA. Uncorrected Fisher's LSD in expression and cytotoxicity analyses adds uncertainty across the multi-line comparisons.

↳ Figures 5a and 6b,d,f; Methods, Data analysis

#methodological rigour

Tissue confirmation lacks reported blinded outcome scoring

Manual transcript counting uses two independent neuropathologists, but blinded assessment is not reported. The comparison includes only three patients and three controls, limiting precision.

↳ Figure 7; Methods, Human post-mortem tissue analysis

Does this match your read? Add your assessment ↓

Nabu Commentary

The edited-line comparisons and complementary molecular, physiological, and pharmacological measurements support a C9ORF72-associated AMPAR phenotype. They do not identify GluA1 upregulation as the unique cause of the functional changes, because JTX blocks Ca2+-permeable receptors generally and the Discussion identifies alternative trafficking mechanisms. Unspecified analysis units and uncorrected multiple comparisons constrain the experimental assessment, while the abstract's selective-vulnerability wording exceeds the single-line cortical receptor comparison. The Discussion nevertheless provides substantive engagement with competing ALS mechanisms and appropriately distinguishes post-mortem association from causation.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.1±0.2

Contribution
3.7

The advance is the linked molecular and functional AMPAR phenotype across patient-derived and edited motor-neuron lines. It meaningfully extends earlier excitotoxicity findings rather than establishing that phenomenon for the first time.

Results, Figures 5–6; Discussion
Methodological Rigour
2.6

Three edited patient-line pairs and converging assays support the receptor phenotype, but the experiments do not isolate GluA1-specific causation. Unspecified inferential units, incomplete antibody validation reporting, and unreported blinded tissue scoring add uncertainty.

Figures 1, 5–6; Methods, Western blot analysis, Human post-mortem tissue analysis, and Data analysis
Reporting
3.2

The sequence from editing to expression, physiology, toxicity, and tissue observations is readable. The headline causal and selective-vulnerability wording exceeds what those comparisons establish, and Figure 5 mislabels one significance result.

Abstract; Figures 1–7; Figure 5 legend
Positioning
3.6

The Discussion engages competing GluA2-editing, receptor-trafficking, and neuron–glia explanations and distinguishes post-mortem association from causation. It does not fully carry the restricted cortical comparison and editing-design limitations into the specificity interpretation.

Discussion, paragraphs on mixed cultures, GluA2 editing, post-mortem causality, and PICK1

Reliability

Caveats4 of 4 checks


Results checkNoted
  • increased expression of GluA1 AMPA receptor (AMPAR) subunit occurs in MNs with C9ORF72 mutations that leads to increased Ca2+-permeable AMPAR expression and results in enhanced selective MN vulnerability to excitotoxicity: "Significant p-values for GluA1 C9-1 vs. Con-1: 0.0039" (Fig. 5 legend) vs "C9-3 vs. Con-1: 0.0503" (Fig. 5 legend). The C9-3 versus Con-1 value listed under significant GluA1 comparisons is 0.0503, which exceeds the stated 0.05 threshold. → Conclusion holds
Reporting and transparencyNoted

The Results name RNAscope whereas the tissue Methods name BaseScope reagents. This is a reporting clarification rather than an established problem with the underlying measurements.

Ethics approval: declared · Data availability: declared

Reference IntegrityNoted

72 of 74 checkable references verified

74 references in manuscript

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 16 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Neurological · Motor neuron disease
Type of advanceEmpirical
Route to useNot stated
AdvanceExtends
BeneficiariesSmall
CitationsFWCI 17.4
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The mechanism is pinned down under controlled laboratory conditions in iPSC-derived neurons with isogenic CRISPR correction, plus correlative post-mortem confirmation, but nothing is shown working in vivo.

The paper presents its findings as elucidating a possible pathogenic mechanism in ALS, with no stated real-world use of the findings beyond further mechanistic understanding and research.

Pathway

Drug developers and ALS trialists could act on these findings by developing and testing Ca2+-permeable AMPAR blockers as neuroprotective therapies for C9ORF72 ALS patients.

Barrier

The mechanism is shown only in cultured iPSC-derived neurons and post-mortem tissue, with no in vivo or clinical evidence that blocking Ca2+-permeable AMPARs slows motor neuron loss in patients.

Evaluated 16 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Astrocytes regulate axonal mitochondrial transport deficits in C9ORF72 amyotrophic lateral sclerosis motor neurons

    Stavrou, Heffernan, Carter, et al. · 2026 · Basic medicine

    Primary claim

    human-induced pluripotent stem-cell-derived astrocytes carrying the C9ORF72 mutation disrupt mitochondrial axonal transport and mitochondrial function in cocultured motor neurons (MNs)

    Supported
    Evidence Score
    3.1±0.1
    Reliability
    Caveats
  2. Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis

    Kasper, Lehto, Jürs, et al. · 2026 · Clinical medicine

    Primary claim

    CSF p-tau and total-tau levels were strongly associated with domain-specific cognitive performance.

    Tentative
    Evidence Score
    3.2±0.2
    Reliability
    Concerns
  3. Short RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration

    Copley, Mauna, Danielson, et al. · 2026 · Basic medicine

    Primary claim

    These short RNAs engage and stabilize the TDP-43 RNA recognition motifs, which allosterically destabilizes a conserved helical region in the prion-like domain, thereby promoting aggregation-resistant conformers.

    Supported
    Evidence Score
    4.1±0.2
    Reliability
    Caveats

How the rubric works →